Sort
51,593 grants matching “hepatitis”
Drug Repurposing Screening for Rare and Neglected Diseases
$1,292,761Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR
Task A10: Efficacy Testing of Therapeutics for Hepatitis C
$1,292,503Kmt Hepatech, Inc. · N01 · FY2012 · AI
Gulf Longitudinal Follow-up (GuLF) Study
$1,292,487Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2012 · ES
Epilepsy Clinical Research Program
$1,291,281University Of Minnesota Twin Cities · P50 · FY2002 · NS
International epidemiologic Database to Evaluate AIDS (West Africa) Core
$1,291,182Francois Dabis · University Of Bordeaux Ii · U01 · FY2009 · AI
Structural studies of native-like SOSIP trimers
$1,290,523Ian A Wilson · Weill Medical Coll Of Cornell Univ · P01 · FY2015 · AI
A novel diagnostic Kit for Hepatocellular Carcinoma
$1,289,036Xuanyong Lu · Imcare Biotech, Inc. · R44 · FY2023 · CA
Stellenbosch University Clinical Trials Unit (SUN-CTU)
$1,287,739Mark Fredric Cotton · Stellenbosch University · UM1 · FY2017 · AI
Alcohol and HIV: Biobehavioral Interactions and Interventions
$1,287,649Peter M. Monti · Brown University · P01 · FY2015 · AA
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study
$1,287,430Philip Todd Korthuis · Oregon Health & Science University · UH3 · FY2021 · DA
Studies on Transfer RNA
$1,287,188Dieter G Soll · Yale University · R01 · FY2011 · GM
Studies on Transfer RNA
$1,287,188Dieter G Soll · Yale University · R01 · FY2012 · GM
Optimizing HIV Care in Less Developed Countries
$1,287,063Kenneth Alan Freedberg · Massachusetts General Hospital · R01 · FY2015 · AI
Pathogenesis and Novel Therapeutic Targets of Fatty Liver Disease and Cancer
$1,286,596Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2020 · AA
Molecular mechanisms of liver injury, repair, and immunity
$1,286,596Bin Gao · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2020 · AA
Studies on Transfer RNA
$1,286,297Dieter G Soll · Yale University · R01 · FY2009 · GM
Optimizing HIV Care in Less Developed Countries
$1,286,165Kenneth Alan Freedberg · Massachusetts General Hospital · R01 · FY2017 · AI
Standard versus High Dose ED-Initiated Buprenorphine Induction
$1,286,024Gail D'onofrio · Yale University · UG1 · FY2023 · DA
Nonalcoholic Steatohepatitis: Natural History, Pathogenesis and Therapy
$1,285,599Yaron Rotman · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Molecular Characterization Of The Mitochondrial Dna Polymerase
$1,285,453William Copeland · National Institute Of Environmental Health Sciences · ZIA · FY2018 · ES
Origin and maturation of protective memory B cell responses against pathogenic viruses in natural infections and upon vaccination.
$1,285,073Mattia Bonsignori · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Center for the Study of Asian-American Health
$1,284,506Mariano J Rey · New York University School Of Medicine · P60 · FY2006 · MD
Center for the Study of Asian-American Health
$1,284,506New York University School Of Medicine · P60 · FY2004 · MD
Integrated Epithelial and Mucosal Biology
$1,284,330Wayne Lencer · Boston Children'S Hospital · P30 · FY2019 · DK
Chicago Clinical Trials Unit
$1,284,164Babafemi O Taiwo · Northwestern University At Chicago · UM1 · FY2021 · AI